Haya therapeutics sa
WebFind company research, competitor information, contact details & financial data for Haya Therapeutics SA of Epalinges, VAUD. Get the latest business insights from Dun & … WebSep 15, 2024 · HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Brian C. Thomas, Ph.D., has joined HAYA as ...
Haya therapeutics sa
Did you know?
WebOct 2, 2024 · 16.12.2024 The 18 most promising biotech startups, according to investors (TOP 100) 14.10.2024 International and seasoned board members for Switzerland (startupticker.ch) 10.02.2024 New US Laboratory and funding for HAYA Therapeutics (startupticker.ch) 09.02.2024 HAYA closes USD 5M seed extension led by Humboldt … WebHAYA Therapeutics SA Route De La Corniche 6 SuperLab Suisse – Batiment Serine 1066 Epalinges, Lausanne Vaud, Switzerland [email protected] San Diego HAYA …
WebHAYA Therapeutics 1,898 (na) tagasubaybay sa LinkedIn. Targeting long non-coding RNAs (lncRNAs) to treat fibrosis -- the RIGHT PLACE, TIME & WAY HAYA … WebMay 21, 2024 · HAYA Therapeutics, SA, société développant des médicaments de précision qui ciblent les ARN longs non codants (lncRNA) spécifiques aux tissus et aux c
WebHAYA Therapeutics SA has 6 investors including Apollo Health Ventures and Viva BioInnovator. How much funding has HAYA Therapeutics SA raised to date? HAYA Therapeutics SA has raised $18M. When was the last funding round for HAYA Therapeutics SA? HAYA Therapeutics SA closed its last funding round on May 5, … WebSep 15, 2024 · HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today …
WebHAYA Therapeutics raised $5,000,000 / Seed from 4See Ventures and 6 other investors . ... HAYA Therapeutics SA raised $18,000,000 / Seed from 4See Ventures and 5 other investors . Discover more funding rounds . View All . Details. Edit Details Section. Founded Date 2024; Operating Status Active; Investor Type Venture Capital Lists Featuring ...
WebFeb 16, 2024 · LAUSANNE, Switzerland & SAN DIEGO, February 16, 2024 -- ( BUSINESS WIRE )-- HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs ... javier\\u0027s newport beach caWebHAYA Therapeutics Appoints Brian C. Thomas, Ph.D., as Chairperson of the Board of Directors LAUSANNE, Switzerland and SAN DIEGO--(BUSINESS WIRE)-- #RNA--Long … javier\u0027s - newport beach newport beach caWebFeb 16, 2024 · LAUSANNE, Switzerland & SAN DIEGO, (BUSINESS WIRE) -- HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today ... javier\u0027s - newport beach newport beachWebHAYA Therapeutics SA Nov 2024 - Apr 2024 1 year 6 months. President & CEO BioTheryX, Inc. Nov 2024 - Jul 2024 9 months. San Diego, … javier\u0027s newport beach reviewsWebFounded Date 2024. Founders Daniel Blessing, Samir Ounzain. Operating Status Active. Last Funding Type Seed. Legal Name HAYA Therapeutics SA. Company Type For … javier\u0027s newport beach dress codeWebHAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health conditions associated with aging, including cancer. The company’s discovery engine focuses on long non-coding RNAs (lncRNAs) within the “dark matter”of the ... javier\u0027s newport beach opentableWebHAYA Therapeutics 3,386 followers on LinkedIn. Inspired to Transform, The Genome Informs - RNA-Guided Therapeutics to Target Disease Causing Cell-States HAYA Therapeutics is a precision ... low profile suspension seat